Koselugo (selumetinib)

pCPA File Number: 22375
Negotiation Status:
Concluded with an LOI
Indication(s):
Neurofibromatosis type 1 in pediatric patients aged 2 years and above, who have symptomatic, inoperable plexiform neurofibromas
Sponsor/Manufacturer:
Alexion Pharma GmbH
CDA-AMC Project Number:
SR0764-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: